Keyphrases
Adenocarcinoma
25%
APC mutation
25%
Appendiceal
25%
Appendiceal Cancer
75%
Appendiceal Neoplasms
100%
Biomarkers Therapeutic Target
50%
Bonferroni
25%
Cambridge
25%
Cancer Cells
25%
Cancer Genes
25%
Chemotherapy
25%
Clinical Laboratory Improvement Amendments
25%
Colorectal Cancer
100%
Epithelial Cancer
25%
Exon
25%
Foundation Medicine
25%
Genomic Landscape
100%
Genomic Profiling
25%
Genotype
25%
GNAS mutation
50%
Goblet Cell Carcinoid
50%
High-grade Tumor
25%
Histological Subtypes
50%
Hybrid Capture
25%
In Cancer
25%
KRAS mutation
25%
Molecular Profiling
25%
Mucinous Adenocarcinoma
25%
Mutation Frequency
25%
Mutation Profiling
50%
Mutation Status
25%
Mutually Exclusive
25%
New Drug Targets
25%
Novel Therapeutic Targets
25%
Overall Survival
75%
Potential Biomarkers
25%
Predictive Biomarker
25%
Prognostic Biomarker
25%
Pseudomyxoma Peritonei
25%
Rare Tumors
25%
Signet Ring Cell Carcinoma
25%
Survival Median
25%
TP53 mutant
25%
TP53 mutation
75%
Treatment Survival
25%
Tumor Grade
25%
Tumor Protein p53 (TP53)
75%
Tumor Specimens
25%
Medicine and Dentistry
Adenocarcinoma
25%
APC
25%
Appendix Tumor
100%
Biological Marker
50%
Cancer
100%
Carcinoid
50%
Colorectal Carcinoma
100%
Exon
25%
Goblet Cell
50%
Intron
25%
Malignant Neoplasm
50%
Medicine
25%
Molecular Profiling
25%
Mucinous Carcinoma
25%
Mutation Rate
25%
Neoplasm
75%
Overall Survival
75%
Pseudomyxoma Peritonei
25%
Rare Tumor
25%
Signet Ring Cell Carcinoma
25%
Tumor-Related Gene
25%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
33%
Exon
33%
Genomics
100%
Genotyping
33%
Goblet Cell
66%
Intron
33%
KRAS
66%
Mutation Rate
33%
Overall Survival
100%
Tumor-Related Gene
33%
Wild Type
33%